IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.286
+0.001 (0.32%)
Mar 6, 2026, 4:00 PM EST - Market closed
IGC Pharma Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$4.25
Upside
+1,386.53%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.75 → $5 | Strong Buy | Maintains | $4.75 → $5 | +1,648.86% | Feb 23, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.5 → $4.75 | Strong Buy | Maintains | $4.5 → $4.75 | +1,561.42% | Dec 9, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.25 → $4.5 | Strong Buy | Maintains | $4.25 → $4.5 | +1,473.98% | Aug 26, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +1,124.20% | Mar 6, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4 → $4.25 | Strong Buy | Maintains | $4 → $4.25 | +1,386.53% | Feb 24, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.75 → $4 | Strong Buy | Maintains | $3.75 → $4 | +1,299.09% | Dec 5, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.5 → $3.75 | Strong Buy | Maintains | $3.5 → $3.75 | +1,211.65% | Sep 3, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.25 → $3.5 | Strong Buy | Maintains | $3.25 → $3.5 | +1,124.20% | Jul 29, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +1,124.20% | Jul 17, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $3.25 | Strong Buy | Reiterates | $3.25 | +1,036.76% | Jun 21, 2024 |